2 not yet recruiting, 1 active not recruiting, 1 completed. 2 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Cue-reactivity: new trials by email Literature Review of Cue-reactivity trials Research Report on Cue-reactivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide for the Treatment of Cannabis Use Disorder semaglutide - Cannabis Use Disorder, Cue-reactivity | Phase 2 | Not yet recruiting | Massachusetts General Hospital | 40 | 2027-01-10 | 2026-10-19 |
| Closed-loop TMS for the Core Clinical Features of Methamphetamine Use Disorder Closed-loop TMS, Conventional TMS, Random TMS - Methamphetamine Use Disorder, Substance Use Disorder | Not applicable | Not yet recruiting | Shanghai Mental Health Center | 21 | 2026-10-01 | 2026-11-02 |
| Closed-loop TBS Targeting rPO for the Core Clinical Features of Methamphetamine Use Disorder Closed-loop Theta-Burst Stimulation (TBS) Targeting rPO - Methamphetamine Use Disorder, Substance Use Disorder | Not applicable | Active not recruiting | Shanghai Mental Health Center | 5 | 2026-08-05 | 2026-11-02 |
| Evaluation of Suvorexant for Reduction of Brain Reactivity in Patients With Cannabis Use Disorder (Pilot Study) Suvorexant - Cue-reactivity, Cannabis Use Disorder | Phase 4 | Completed | Massachusetts General Hospital | 20 | 2025-03-10 | 2026-07-01 |
Substance-Related Disorders (2)
Chemically-Induced Disorders (2) · Mental Disorders (2)
semaglutide (1) · suvorexant (1)
Massachusetts General Hospital (2) · Shanghai Mental Health Center (2)
China (2) · United States (1)
Jodi Gilman, PhD (1) · Jodi M Gilman, PhD (1) · Min Zhao, PhD (1)